NEUROCRINE BIOSCIENCES INC (NBIX) Gross margin 2016–2025
NEUROCRINE BIOSCIENCES INC (NBIX) gross margin by fiscal year — reported gross profit divided by reported revenue.
98.2%FY2025 · since FY2016: 100.0% → 98.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 98.2% | -0.4 pp |
| FY2024 | 98.6% | +0.7 pp |
| FY2023 | 97.9% | -0.5 pp |
| FY2022 | 98.4% | -0.3 pp |
| FY2021 | 98.7% | -0.3 pp |
| FY2020 | 99.0% | — |
| FY2018 | 98.9% | -0.3 pp |
| FY2017 | 99.2% | -0.8 pp |
| FY2016 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More NBIX financial trends
NBIX RevenueNBIX Net incomeNBIX Net marginNBIX Gross profitNBIX Operating incomeNBIX Operating marginNBIX Operating cash flowNBIX Free cash flowNBIX Capital expendituresNBIX Return on equityNBIX Stock buybacksNBIX Dividends paidNBIX Total assetsNBIX Total liabilitiesNBIX Shareholders’ equityNBIX overview →